APA (7th ed.) Citation

JS, L., P, H., R, C., S, K., S, B., MD, M., . . . TM, F. (2021). Author Correction: Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycin. Nature biomedical engineering, 5(11), 1403. https://doi.org/10.1038/s41551-021-00828-4

Chicago Style (17th ed.) Citation

JS, Lee, et al. "Author Correction: Metabolic and Immunomodulatory Control of Type 1 Diabetes via Orally Delivered Bile-acid-polymer Nanocarriers of Insulin or Rapamycin." Nature Biomedical Engineering 5, no. 11 (2021): 1403. https://doi.org/10.1038/s41551-021-00828-4.

MLA (9th ed.) Citation

JS, Lee, et al. "Author Correction: Metabolic and Immunomodulatory Control of Type 1 Diabetes via Orally Delivered Bile-acid-polymer Nanocarriers of Insulin or Rapamycin." Nature Biomedical Engineering, vol. 5, no. 11, 2021, p. 1403, https://doi.org/10.1038/s41551-021-00828-4.